We found a similar expression pattern for CEACAM20 in normal vs malignant prostate using immunohistochemistry staining (IHC), suggesting the possibility that down regulation of CEACAM1 and/or CEACAM20 is responsible for the absence of lumina in high Gleason grade prostate cancer. The gene discussed is CEACAM20; the disease is prostate carcinoma.